C45H42ClN3O5S — CID 126191864
N-benzhydryl-2-[(5E)-5-[[4-[(2-chlorophenyl)methoxy]-3-ethoxy-5-prop-2-enylphenyl]methylidene]-1-[(2E,4Z)-hepta-2,4,6-trien-3-yl]-4,6-dioxopyrimidin-2-yl]sulfanylacetamide (PubChem CID 126191864) has the molecular formula C45H42ClN3O5S and a molecular weight of 772.37 g/mol. Its IUPAC name is N-benzhydryl-2-[(5E)-5-[[4-[(2-chlorophenyl)methoxy]-3-ethoxy-5-prop-2-enylphenyl]methylidene]-1-[(2E,4Z)-hepta-2,4,6-trien-3-yl]-4,6-dioxopyrimidin-2-yl]sulfanylacetamide.
| Compound Name | N-benzhydryl-2-[(5E)-5-[[4-[(2-chlorophenyl)methoxy]-3-ethoxy-5-prop-2-enylphenyl]methylidene]-1-[(2E,4Z)-hepta-2,4,6-trien-3-yl]-4,6-dioxopyrimidin-2-yl]sulfanylacetamide |
|---|---|
| PubChem CID | 126191864 |
| Molecular Formula | C45H42ClN3O5S |
| Molecular Weight | 772.37 g/mol |
| Exact Mass | 771.25 |
| IUPAC Name | N-benzhydryl-2-[(5E)-5-[[4-[(2-chlorophenyl)methoxy]-3-ethoxy-5-prop-2-enylphenyl]methylidene]-1-[(2E,4Z)-hepta-2,4,6-trien-3-yl]-4,6-dioxopyrimidin-2-yl]sulfanylacetamide |
| SMILES | C=C/C=C\C(=C/C)N1C(=O)/C(=C/c2cc(CC=C)c(OCc3ccccc3Cl)c(OCC)c2)C(=O)N=C1SCC(=O)NC(c1ccccc1)c1ccccc1 |
| InChI | InChI=1S/C45H42ClN3O5S/c1-5-9-24-36(7-3)49-44(52)37(27-31-26-34(18-6-2)42(39(28-31)53-8-4)54-29-35-23-16-17-25-38(35)46)43(51)48-45(49)55-30-40(50)47-41(32-19-12-10-13-20-32)33-21-14-11-15-22-33/h5-7,9-17,19-28,41H,1-2,8,18,29-30H2,3-4H3,(H,47,50)/b24-9-,36-7+,37-27+ |
| InChIKey | NIYKSZBHQNSYCO-DJOROMSESA-N |
| XLogP | 9.44 |
| TPSA | 97.30 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 55 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 772.37 |
| LogP ≤ 5 | 9.44 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
| Structural Alerts | {'alert_name': 'ene_six_het_A(483)', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_4', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'} |
|---|